LY-2940094

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameLY-2940094
Drug Alias NameLY-2940094BTRX-246040
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNociceptin receptor agonists
TargetsNociceptin receptor
Therapy Area/IndicationsDepressive Disorder, MajorAnxiety DisordersAnxiety +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesBrown UniversityUniversity Of WashingtonMassachusetts Institute Of Technology
Inactive CompaniesBlackthorn Therapeutics IncNational Institute Of Mental Health (Nimh)
Active IndicationsDepressive Disorder, MajorAnxiety Disorders
Inactive IndicationsAnxietyStress, PsychologicalAlcoholism +[5] 

Other Information

ATC CodeN/A
Related LinksWikipedia